Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 – April 1, 2016, Tours, France

Monoclonal antibody (mAb) therapeutics have tremendous potential to benefit patients with lung diseases, for which there remains substantial unmet medical need. To capture the current state of mAb research and development in the area of respiratory diseases, the Research Center of Respiratory Diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Desoubeaux, Guillaume, Reichert, Janice M., Sleeman, Matthew, Reckamp, Karen L., Ryffel, Bernhard, Adamczewski, Jörg P., Sweeney, Theresa D., Vanbever, Rita, Diot, Patrice, Owen, Caroline A., Page, Clive, Lerondel, Stéphanie, Le Pape, Alain, Heuze-Vourc'h, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968091/
https://www.ncbi.nlm.nih.gov/pubmed/27266390
http://dx.doi.org/10.1080/19420862.2016.1196521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968091/
https://www.ncbi.nlm.nih.gov/pubmed/27266390
http://dx.doi.org/10.1080/19420862.2016.1196521

Ejemplares similares